Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-08-15
DRNADicerna Pharmaceuticals IncLanger DennisDirS - Sale$16.00-38,34177,042-33%-$613,456
D
2018-08-17
CORICorium International, Inc.Sweemer Timothy DChief Accounting OfficerS - Sale+OE$9.01-34634,801-1%-$3,117
D
2018-08-17
CORICorium International, Inc.Singh ParminderCTO, VP, R, DS - Sale+OE$9.01-3,13315,870-16%-$28,224
D
2018-08-17
CORICorium International, Inc.Sarret Joseph J.Chief Business OfficerS - Sale+OE$9.01-3,56516,210-18%-$32,116
D
2018-08-17
CORICorium International, Inc.Breuil Robert SCFOS - Sale+OE$9.01-97214,441-6%-$8,756
DM
2018-08-16
CORICorium International, Inc.Staple Peter DPres, CEOS - Sale+OE$8.81-76,341282,747-21%-$672,524
D
2018-08-15
CORICorium International, Inc.Thomas RobertDirS - Sale+OE$8.86-35,6080-100%-$315,476
M
2016-05-18
BSTCBiospecifics Technologies CorpEstate of Edwin H. Wegman10%S - Sale$38.22-57,705947,473-6%-$2,205,474
2018-08-17
BSTCBiospecifics Technologies CorpWegman TobyDir, 10%S - Sale$51.89-2,500947,4730%-$129,728
M
2018-08-16
BSTCBiospecifics Technologies CorpWegman ThomasPres, 10%S - Sale$51.30-23,5921,238,800-2%-$1,210,294
M
2018-08-16
LGNDLigand Pharmaceuticals IncAryeh JasonDirS - Sale$241.94-27,942115,535-19%-$6,760,159
M
2018-08-16
LGNDLigand Pharmaceuticals IncDavis Todd CDirS - Sale$239.78-9,00045,056-17%-$2,158,002
DM
2018-08-16
LGNDLigand Pharmaceuticals IncHiggins John LCEOS - Sale+OE$241.96-34,50088,919-28%-$8,347,560
D
2018-08-16
LGNDLigand Pharmaceuticals IncPatel SunilDirS - Sale+OE$240.05-42,28724,524-63%-$10,150,808
D
2018-08-17
XNCRXencor IncFoster Paul AChief Medical OfficerS - Sale+OE$40.10-3,6594,952-42%-$146,726
2018-08-16
CLRBCellectar Biosciences, Inc.Longcor JarrodChief Business OfficerP - Purchase$2.71+5007,200+7%+$1,355
D
2018-08-16
FGENFibrogen IncRosenkranz Roberto PedroDirS - Sale+OE$60.28-1,00032,700-3%-$60,279
D
2018-08-16
FGENFibrogen IncKurkijarvi KaleviDirS - Sale+OE$60.28-4,00023,700-14%-$241,128
D
2018-08-15
ARNAArena Pharmaceuticals IncSpector Steven WEVP, GC, SecS - Sale+OE$36.01-29,00519,690-60%-$1,044,505
2018-08-15
ACRSAclaris Therapeutics, Inc.Tullman Stephen A.DirP - Purchase$15.97+6,250557,771+1%+$99,813
2018-08-15
ARRYArray Biopharma IncHaddock JasonCFOS - Sale$13.92-20,00035,393-36%-$278,400
D
2018-08-15
ARRYArray Biopharma IncVan Lunsen Gil JDirS - Sale+OE$13.92-21,50019,297-53%-$299,280
DM
2018-08-15
ATNXAthenex, Inc.Zhang Song-YiDir, 10%S - Sale+OE$16.65-105,0526,708,917-2%-$1,749,363
2018-08-16
UTHRUnited Therapeutics CorpGiltner RichardDirS - Sale$129.38-3,2400-100%-$419,198
2018-08-16
AMPHAmphastar Pharmaceuticals, Inc.Peters William JCFO, SVP, TreasurerS - Sale$17.59-2,40786,836-3%-$42,333
2018-08-17
STDYSteadymed Ltd.Rigby JonathanPres, CEOS - Sale$4.66-88,83146,565-66%-$413,739
M
2018-08-15
INFIInfinity Pharmaceuticals, Inc.Kutok JefferyChief Scientific OfficerS - Sale$2.00-14,3139,542-60%-$28,687
2018-08-16
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$104.50-200,000120,355,8040%-$20,899,800
D
2018-08-15
GTHXG1 Therapeutics, Inc.Malik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$55.89-3,7768,400-31%-$211,023
D
2018-08-15
GTHXG1 Therapeutics, Inc.Velleca Mark A.Pres, CEOS - Sale+OE$55.88-5,0009,000-36%-$279,378
2018-08-14
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.02+58,20025,567,1980%+$1,153
2018-08-14
OVIDOvid Therapeutics Inc.Bernstein KarenDirP - Purchase$6.23+10,00010,000New+$62,300
2018-08-14
OVIDOvid Therapeutics Inc.Williams Douglas EDirP - Purchase$6.49+5,0005,000New+$32,442
M
2018-08-14
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$0.65+529,3706,541,163+9%+$342,879
DM
2018-08-14
XNCRXencor IncFoster Paul AChief Medical OfficerS - Sale+OE$41.10-36,3414,952-88%-$1,493,710
M
2018-08-14
BLPHBellerophon Therapeutics, Inc.Venrock Associates IV L P10%P - Purchase$0.65+529,3706,541,163+9%+$342,879
M
2018-08-14
TBPHTheravance Biopharma, Inc.Gala Renee DSVP, CFOS - Sale$26.79-43,743171,049-20%-$1,171,791
2018-08-15
JAZZJazz Pharmaceuticals PlcYoung Matthew P.EVP, CFOS - Sale$176.05-70034,168-2%-$123,235
M
2018-08-14
CORTCorcept Therapeutics IncBaker G Leonard JrDirP - Purchase$12.48+179,6864,525,213+4%+$2,241,967
M
2018-08-14
RCUSArcus Biosciences, Inc.Rosen Terry JCEOP - Purchase$12.64+28,4014,112,467+1%+$359,127
D
2018-08-15
PCRXPacira Pharmaceuticals, Inc.Stack David MCEO, COBS - Sale+OE$47.32-33,062111,487-23%-$1,564,432
2018-08-14
PCRXPacira Pharmaceuticals, Inc.Williams Kristen MarieCAO, GCS - Sale$47.04-4,77322,374-18%-$224,522
M
2018-08-14
VRCAVerrica Pharmaceuticals Inc.White TedPres, CEOP - Purchase$15.69+2,5057,005+56%+$39,310
2018-08-14
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickEVP, US CommercialS - Sale$175.70-20025,572-1%-$35,140
D
2018-08-15
ZTSZoetis Inc.Knupp Catherine A.EVPS - Sale+OE$90.84-46,81634,824-57%-$4,252,765
2018-08-14
ALBOAlbireo Pharma, Inc.Cooper Ronald Harold WilfredPres, CEOP - Purchase$31.85+7886,734+13%+$25,098
M
2018-08-14
ALRNAileron Therapeutics IncNovartis Bioventures Ltd10%S - Sale$2.21-5,9352,434,7780%-$13,123
2018-08-14
ZYMEZymeworks Inc.Lilly Eli & Co10%S - Sale$14.28-3,0003,926,6060%-$42,840
2018-08-14
PRGOPerrigo Co PlcAndersen SvendEVP, Pres CHCIP - Purchase$69.43+7,2007,200New+$499,896
M
2018-08-14
RDUSRadius Health, Inc.Biotech Growth N V10%P - Purchase$20.83+169,3636,530,276+3%+$3,528,410
2018-08-15
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$103.23-151,793120,555,8040%-$15,669,440
2018-08-13
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+53,00025,508,9980%+$1,378
M
2018-08-07
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+48,50025,455,9980%+$1,402
2018-08-15
SRPTSarepta Therapeutics, Inc.Ingram Douglas SPres, CEOP - Purchase$125.26+16,000399,250+4%+$2,004,211
2018-08-15
KERXKeryx Biopharmaceuticals IncHolmes Scott ACFOS - Sale$3.04-1,185165,365-1%-$3,602
2018-08-15
KERXKeryx Biopharmaceuticals IncNeylan John F.Chief Medical OfficerS - Sale$3.04-1,186150,688-1%-$3,605
DM
2018-08-13
PAHCPhibro Animal Health CorpBendheim JackPres, CEO, 10%S - Sale+OE$49.75-30,00030,000-50%-$1,492,600
DM
2018-08-13
PAHCPhibro Animal Health CorpBfi Co., LLC10%S - Sale+OE$49.75-30,00030,000-50%-$1,492,600
M
2018-08-14
BSTCBiospecifics Technologies CorpWegman ThomasPresS - Sale$50.81-23,908312,419-7%-$1,214,703
M
2018-08-13
NKTRNektar TherapeuticsWinger Dennis LDirS - Sale$60.59-34,25047,750-42%-$2,075,379
M
2018-08-14
EVFMEvofem Biosciences, Inc.Lynch Thomas GDirP - Purchase$2.26+100,000175,000+133%+$225,854
M
2018-08-13
ODTOdonate Therapeutics, Inc.Tang Kevin CCEO, 10%P - Purchase$18.93+22,81012,435,1480%+$431,705
DM
2018-08-13
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerS - Sale+OE$159.34-10,00013,700-42%-$1,593,446
DM
2018-08-13
LOXOLoxo Oncology, Inc.Burstein JenniferSVP of FinanceS - Sale+OE$159.24-2,5000-100%-$398,105
DM
2018-08-13
LOXOLoxo Oncology, Inc.Bilenker Joshua H.Pres, CEOS - Sale+OE$159.41-20,000165,407-11%-$3,188,181
2018-08-14
OCULOcular Therapeutix, IncNotman DonaldCFOP - Purchase$6.29+12,50017,300+260%+$78,625
D
2018-08-13
CTXRCitius Pharmaceuticals, Inc.Mazur Leonard LExec COB, 10%P - Purchase$1.27+3,137,2556,855,595+84%+$4,000,000
D
2018-08-13
CTXRCitius Pharmaceuticals, Inc.Holubiak Myron ZPres, CEO, 10%P - Purchase$1.27+784,3141,304,196+151%+$1,000,000
D
2018-08-13
VCNXVaccinex, Inc.Friedberg AlbertDir, 10%P - Purchase$12.00+2,458,3335,848,990+73%+$29,499,996
2018-06-19
VRCAVerrica Pharmaceuticals Inc.White TedPres, CEOP - Purchase$15.00+4,5004,500New+$67,500
2018-06-19
VRCAVerrica Pharmaceuticals Inc.Palczuk LindaCOOP - Purchase$15.00+3,0003,000New+$45,000
2018-06-19
VRCAVerrica Pharmaceuticals Inc.Degnan ChrisCFOP - Purchase$15.00+3,0003,000New+$45,000
2018-06-19
VRCAVerrica Pharmaceuticals Inc.Bonaccorso JoeChief Commercial OfficerP - Purchase$15.00+1,0001,000New+$15,000
2018-06-19
VRCAVerrica Pharmaceuticals Inc.Manning Paul BDir, 10%P - Purchase$15.00+300,0009,504,661+3%+$4,500,000
2018-08-13
ICUIIcu Medical Inc/dePfizer IncDir, 10%S - Sale$284.35-700,0002,500,000-22%-$199,045,000
D
2018-08-14
AMPHAmphastar Pharmaceuticals, Inc.Prins Richard KDirS - Sale+OE$17.82-10,00035,434-22%-$178,180
2018-08-14
DOVADova Pharmaceuticals, Inc.Sapir AlexPres, CEOP - Purchase$22.83+21,70068,609+46%+$495,411
M
2018-08-13
EBSEmergent Biosolutions Inc.El-Hibri FuadCOB, 10%S - Sale$55.98-36,3187,357,0800%-$2,033,109
D
2018-08-14
ZTSZoetis Inc.Alaix Juan RamonCEOS - Sale+OE$91.55-135,00096,013-58%-$12,359,250
2018-08-13
BGNEBeigene, Ltd.Wang XiaodongDirS - Sale$158.77-3,44913,152,9790%-$547,591
2018-08-14
ENDPEndo International PlcKimmel Roger HDirS - Sale$15.90-26,074265,277-9%-$414,577
A
2018-08-13
ABUSArbutus Biopharma CorpSofia Michael J.Chief Scientific OfficerS - Sale$9.51-4,2501,670,5650%-$40,436
2018-08-15
OPTNOptinose, Inc.Gibbs Thomas EdwardChief Commercial OfficerP - Purchase$12.69+2,0003,985+101%+$25,380
2018-08-15
CLSNCelsion CorpFritz Frederick J.DirP - Purchase$2.39+5,50027,841+25%+$13,145
2018-08-15
OPTNOptinose, Inc.Miller Peter KCEOP - Purchase$14.32+10,752117,738+10%+$153,969
2018-08-10
IMMYImprimis Pharmaceuticals, Inc.Kammer Robert JDirS - Sale$3.00-130,000929,827-12%-$390,000
D
2018-08-10
AVDLAvadel Pharmaceuticals PlcAnderson Michael SCEOS - Sale+OE$4.91-16,297248,953-6%-$79,953
D
2018-08-10
AVDLAvadel Pharmaceuticals PlcHatten Sandra LSee RemarksS - Sale+OE$4.91-6,29047,410-12%-$30,859
2018-08-10
ALRNAileron Therapeutics IncLongenecker John P PhdPres, CEOP - Purchase$2.45+10,00010,000New+$24,500
2018-08-10
KPTIKaryopharm Therapeutics Inc.Chione Ltd10%S - Sale$18.50-7028,261,5610%-$12,987
2018-08-13
ABUSArbutus Biopharma CorpSofia Michael J.Chief Scientific OfficerS - Sale$9.51-4,2501,670,5650%-$40,436
M
2018-08-13
PETXAratana Therapeutics, Inc.Heinen ErnstChief Development OfficerS - Sale$5.15-10,372155,694-6%-$53,416
M
2018-08-10
ALRNAileron Therapeutics IncNovartis Bioventures Ltd10%S - Sale$2.42-7,2152,440,7130%-$17,477
M
2018-08-10
ZYMEZymeworks Inc.Lilly Eli & Co10%S - Sale$14.32-6,4293,929,6060%-$92,033
2018-08-13
PFEPfizer IncOlson Laurie JEVPS - Sale$41.00-10,21478,201-12%-$418,774
D
2018-08-10
VTVTVtv Therapeutics Inc.Perelman Ronald O10%P - Purchase$4.38+570,7774,898,771+13%+$2,500,003
2018-08-10
VRCAVerrica Pharmaceuticals Inc.Manning Paul BDir, 10%P - Purchase$15.08+33,0009,204,6610%+$497,640
A
2017-07-05
ALRNAileron Therapeutics IncKapnick ScottDir, 10%P - Purchase$15.00+66,66666,666New+$999,990
2018-08-10
ZGNXZogenix, Inc.Perceptive Advisors LLC10%P - Purchase$52.00+100,0004,070,357+3%+$5,200,000
2018-08-13
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$5.33+15,000191,702,3260%+$79,932

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top